KEGG   PATHWAY: gvr05216
Entry
gvr05216                    Pathway                                
Name
Thyroid cancer - Galeopterus variegatus (Sunda flying lemur)
Description
Thyroid cancer is the most common endocrine malignancy and accounts for the majority of endocrine cancer- related deaths each year. More than 95% of thyroid carcinomas are derived from follicular cells. Their behavior varies from the indolent growing, well-differentiated papillary and follicular carcinomas (PTC and FTC, respectively) to the extremely aggressive undifferentiated carcinoma (UC). Somatic rearrangements of RET and TRK are almost exclusively found in PTC and may be found in early stages. The most distinctive molecular features of FTC are the prominence of aneuploidy and the high prevalence of RAS mutations and PAX8-PPAR{gamma} rearrangements. p53 seems to play a crucial role in the dedifferentiation process of thyroid carcinoma.
Class
Human Diseases; Cancer: specific types
Pathway map
gvr05216  Thyroid cancer
gvr05216

Disease
H00032  Thyroid cancer
Organism
Galeopterus variegatus (Sunda flying lemur) [GN:gvr]
Gene
103585943  CDH1; cadherin-1 [KO:K05689]
103585949  TCF7L1; transcription factor 7-like 1 isoform X1 [KO:K04490]
103587762  BAX; apoptosis regulator BAX isoform X1 [KO:K02159]
103587820  MYC; myc proto-oncogene protein [KO:K04377]
103588322  NCOA4; nuclear receptor coactivator 4 isoform X1 [KO:K09289]
103588373  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
103588563  NTRK1; high affinity nerve growth factor receptor isoform X1 [KO:K03176] [EC:2.7.10.1]
103589124  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
103589329  NRAS; GTPase NRas [KO:K07828]
103590576  TPR; nucleoprotein TPR [KO:K09291]
103590613  PPARG; peroxisome proliferator-activated receptor gamma [KO:K08530]
103591400  TP53; cellular tumor antigen p53 [KO:K04451]
103591675  RXRA; retinoic acid receptor RXR-alpha [KO:K08524]
103592005  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
103592096  DDB2; DNA damage-binding protein 2 [KO:K10140]
103592192  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
103592399  TCF7; transcription factor 7 isoform X1 [KO:K02620]
103593743  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
103595759  PAX8; paired box protein Pax-8 [KO:K09293]
103596129  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
103596180  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
103597016  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
103597936  RXRB; retinoic acid receptor RXR-beta isoform X1 [KO:K08525]
103598508  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]
103598782  [KO:K09288]
103599501  KRAS; GTPase KRas [KO:K07827]
103599851  BAK1; bcl-2 homologous antagonist/killer [KO:K14021]
103600170  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:2.7.12.2]
103600324  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
103600945  CTNNB1; catenin beta-1 isoform X1 [KO:K02105]
103605929  RET; proto-oncogene tyrosine-protein kinase receptor Ret [KO:K05126] [EC:2.7.10.1]
103606499  CCDC6; coiled-coil domain-containing protein 6 [KO:K09288]
103607082  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
103607313  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
103607349  RXRG; retinoic acid receptor RXR-gamma [KO:K08526]
103607884  TPM3; tropomyosin alpha-3 chain isoform X1 [KO:K09290]
103608170  [KO:K09292]
103610513  HRAS; GTPase HRas isoform X1 [KO:K02833]
Reference
  Authors
Kondo T, Ezzat S, Asa SL.
  Title
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
  Journal
Nat Rev Cancer 6:292-306 (2006)
DOI:10.1038/nrc1836
Reference
  Authors
Chiloeches A, Marais R.
  Title
Is BRAF the Achilles' Heel of thyroid cancer?
  Journal
Clin Cancer Res 12:1661-4 (2006)
DOI:10.1158/1078-0432.CCR-06-0051
Reference
  Authors
Reddi HV, McIver B, Grebe SK, Eberhardt NL
  Title
The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
  Journal
Endocrinology 148:932-5 (2007)
DOI:10.1210/en.2006-0926
Reference
  Authors
Santoro M, Melillo RM, Fusco A.
  Title
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
  Journal
Eur J Endocrinol 155:645-653 (2006)
DOI:10.1530/eje.1.02289
Reference
  Authors
Pierotti MA, Greco A.
  Title
Oncogenic rearrangements of the NTRK1/NGF receptor.
  Journal
Cancer Lett 232:90-8 (2006)
DOI:10.1016/j.canlet.2005.07.043
Reference
  Authors
Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.
  Title
Molecular pathology of well-differentiated thyroid carcinomas.
  Journal
Virchows Arch 447:787-93 (2005)
DOI:10.1007/s00428-005-0065-5
Reference
  Authors
Gimm O.
  Title
Thyroid cancer.
  Journal
Cancer Lett 163:143-56 (2001)
DOI:10.1016/S0304-3835(00)00697-2
Reference
  Authors
Williams D.
  Title
Cancer after nuclear fallout: lessons from the Chernobyl accident.
  Journal
Nat Rev Cancer 2:543-9 (2002)
DOI:10.1038/nrc845
Related
pathway
gvr03320  PPAR signaling pathway
gvr04010  MAPK signaling pathway
gvr04115  p53 signaling pathway
gvr04310  Wnt signaling pathway
gvr04520  Adherens junction
KO pathway
ko05216   

DBGET integrated database retrieval system